{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:01:00Z","timestamp":1787238060927,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T00:00:00Z","timestamp":1306281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2474-12-113","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T02:18:29Z","timestamp":1306376309000},"source":"Crossref","is-referenced-by-count":75,"title":["Reversal of TGF-\u03b21 stimulation of \u03b1-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's - derived fibroblasts"],"prefix":"10.1186","volume":"12","author":[{"given":"Latha","family":"Satish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip H","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Baratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kathju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,25]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.12968\/hmed.2007.68.11.27683","volume":"68","author":"A Bayat","year":"2007","unstructured":"Bayat A, Cunliffe EJ, McGrouther DA: Assessment of clinical severity in Dupuytren's disease. Br J Hosp Med. 2007, 68: 604-609.","journal-title":"Br J Hosp Med"},{"key":"1150_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-0712(21)00436-4","volume":"15","author":"JJ Tomasek","year":"1999","unstructured":"Tomasek JJ, Vaughan MB, Haaksma CJ: Cellular structure and biology of Dupuytren's disease. Hand Clin. 1999, 15: 21-34.","journal-title":"Hand Clin"},{"key":"1150_CR3","first-page":"222","volume":"2","author":"G Dupuytren","year":"1884","unstructured":"Dupuytren G: Permanent retraction of the fingers, produced by an affection of the palmar fascia. Clinical lectures on surgery. Lancet. 1884, 2: 222-","journal-title":"Lancet"},{"key":"1150_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0363-5023(05)80067-X","volume":"20A","author":"P Kloen","year":"1995","unstructured":"Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ: TGF-beta:possible roles in Dupuytren's contracture. J Hand Surg. 1995, 20A: 101-108.","journal-title":"J Hand Surg"},{"key":"1150_CR5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","volume":"41-A","author":"JV Luck","year":"1959","unstructured":"Luck JV: Dupuytren's contracture: a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg [Am]. 1959, 41-A: 635-664.","journal-title":"J Bone Joint Surg [Am]"},{"key":"1150_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0363-5023(78)80112-9","volume":"3","author":"HF Chiu","year":"1978","unstructured":"Chiu HF, McFarlane RM: Pathogenesis of Dupuytren's contracture: a correlative clinic-pathological study. J Hand Surg. 1978, 3: 1-10.","journal-title":"J Hand Surg"},{"key":"1150_CR7","first-page":"31","volume-title":"Dupuytren's disease: biology and treatment","author":"W Sch\u00fcrch","year":"1990","unstructured":"Sch\u00fcrch W, Skalli O, Gabbiani G: Cellular biology. Dupuytren's disease: biology and treatment. Edited by: McFarlane RM, McGrouther DA, Flint MH. 1990, London: Churchill Livingstone, 31-47."},{"key":"1150_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/excr.1999.4543","volume":"250","author":"G Serini","year":"1999","unstructured":"Serini G, Gabbiani G: Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999, 250: 273-283. 10.1006\/excr.1999.4543.","journal-title":"Exp Cell Res"},{"key":"1150_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1302\/0301-620X.85B3.13219","volume":"85","author":"HB Hindman","year":"2003","unstructured":"Hindman HB, Marty-Roix R, Tang JB, Jupiter JB, Simmons BP, Spector M: Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture. J Bone Joint Surg Br. 2003, 85: 448-455. 10.1302\/0301-620X.85B3.13219.","journal-title":"J Bone Joint Surg Br"},{"key":"1150_CR10","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1111\/j.1469-7793.1999.001af.x","volume":"277","author":"DW Powell","year":"1999","unstructured":"Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol. 1999, 277: C1-C9.","journal-title":"Am J Physiol"},{"key":"1150_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","volume":"21A","author":"MA Badalamente","year":"1996","unstructured":"Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K: The role of TGF-beta in Dupuytren's disease. J Hand Surg. 1996, 21A: 210-215.","journal-title":"J Hand Surg"},{"key":"1150_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0363-5023(94)90058-2","volume":"19A","author":"RL Zamaro","year":"1994","unstructured":"Zamaro RL, Heights R, Kraemer BA, Ehrlich HP, Groner JP: Presence of growth factors in palmar and plantar fibromatoses. J Hand Surg. 1994, 19A: 435-441.","journal-title":"J Hand Surg"},{"key":"1150_CR13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/BF02389692","volume":"27","author":"A Berndt","year":"1995","unstructured":"Berndt A, Kosmehl H, Mandel U, Gabler U, Leo X, Celeda D, Zardi L, Katenkamp D: TGF-beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J. 1995, 27: 1014-1020.","journal-title":"Histochem J"},{"key":"1150_CR14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2106\/00004623-197658030-00016","volume":"58A","author":"JJ Rodrigo","year":"1976","unstructured":"Rodrigo JJ, Niebauer JJ, Brown RL, Doyle JR: Treatment of Dupuytren's contracture-long-term results after fasciotomy and fascial excision. J Bone Joint Surg. 1976, 58A: 380-387.","journal-title":"J Bone Joint Surg"},{"key":"1150_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jhsb.2006.05.005","volume":"31B","author":"JJ Dias","year":"2006","unstructured":"Dias JJ, Braybrooke J: Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg. 2006, 31B: 514-521.","journal-title":"J Hand Surg"},{"key":"1150_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jhsa.2007.04.002","volume":"32A","author":"MA Badalamente","year":"2007","unstructured":"Badalamente MA, Hurst LC: Efficacy and safety of injectable missed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg. 2007, 32A: 767-774.","journal-title":"J Hand Surg"},{"key":"1150_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2106\/00004623-198062030-00012","volume":"62A","author":"RH Gelberman","year":"1980","unstructured":"Gelberman RH, Amiel D, Rudolph RM, Vance RM: Dupuytren's contracture. An electron microscopic, biochemical, and clinical correlative study. J Bone Joint Surg. 1980, 62A: 425-432.","journal-title":"J Bone Joint Surg"},{"key":"1150_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.ph.56.030194.001321","volume":"56","author":"SH Francis","year":"1994","unstructured":"Francis SH, Corbin JD: Structure and function of cyclic nucleotide-dependent protein kinases. Ann rev Physiol. 1994, 56: 237-272. 10.1146\/annurev.ph.56.030194.001321.","journal-title":"Ann rev Physiol"},{"key":"1150_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1146\/annurev.biochem.66.1.807","volume":"66","author":"M Montminy","year":"1997","unstructured":"Montminy M: Transcriptional regulation by cyclic AMP. Annu Rev Biochem. 1997, 66: 807-822. 10.1146\/annurev.biochem.66.1.807.","journal-title":"Annu Rev Biochem"},{"key":"1150_CR20","doi-asserted-by":"publisher","first-page":"C1089","DOI":"10.1152\/ajpcell.00461.2003","volume":"286","author":"X Liu","year":"2004","unstructured":"Liu X, Ostrom RS, Insel PA: cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol. 2004, 286: C1089-C1099.","journal-title":"Am J Physiol"},{"key":"1150_CR21","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1073\/pnas.0408704102","volume":"102","author":"JS Swaney","year":"2005","unstructured":"Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros GJ, Insel PA: Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci USA. 2005, 102: 437-442. 10.1073\/pnas.0408704102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1150_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jss.2004.01.013","volume":"117","author":"JC Howard","year":"2004","unstructured":"Howard JC, Varallo VM, Ross DC, Faber KJ, Roth JH, Seney S, Gan BS: Wound healing-assoociated proteins Hsp47 and fibronectin are elevated in Dupuytren's contracture. J Surg Res. 2004, 117: 232-238. 10.1016\/j.jss.2004.01.013.","journal-title":"J Surg Res"},{"key":"1150_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1755-8794-1-10","volume":"1","author":"L Satish","year":"2008","unstructured":"Satish L, Laframboise WA, O'Gorman DB, Johnson S, Janto B, Gan BS, Baratz ME, Hu FZ, Post JC, Ehrlich GD, Kathju S: Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture. BMC Med Genomics. 2008, 1: 10-10.1186\/1755-8794-1-10.","journal-title":"BMC Med Genomics"},{"key":"1150_CR24","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1074\/jbc.M312549200","volume":"279","author":"M B\u00f6hm","year":"2004","unstructured":"B\u00f6hm M, Raghunath M, Sunderk\u00f6tter C, Schiller M, St\u00e4nder S, Brzoska T, Cauvet T, Schi\u00f6th HB, Schwartz T, Luger TA: Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. J Biol Chem. 2004, 279: 6959-6966.","journal-title":"J Biol Chem"},{"key":"1150_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/jbc.M109.038620","volume":"285","author":"M Schiller","year":"2010","unstructured":"Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, Mauviel A, B\u00f6hm M: Increased cAMP levels modulate TGF-\u03b2\/Smad-induced expression of extracellular matrix components and other key fibroblast functions. J Biol Chem. 2010, 285: 409-421. 10.1074\/jbc.M109.038620.","journal-title":"J Biol Chem"},{"key":"1150_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archotol.133.9.919","volume":"133","author":"HS Li-Korotky","year":"2007","unstructured":"Li-Korotky HS, Hebda PA, Lo CY, Dohar JE: Age-dependent differential expression of fibronectin variants in skin and airway mucosal wounds. Arch Otolaryngol Head Neck Surg. 2007, 133: 919-924. 10.1001\/archotol.133.9.919.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1150_CR27","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1074\/jbc.M611742200","volume":"282","author":"J Pannu","year":"2007","unstructured":"Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M: Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1\/2 pathways. J Biol Chem. 2007, 282: 10405-14013. 10.1074\/jbc.M611742200.","journal-title":"J Biol Chem"},{"key":"1150_CR28","doi-asserted-by":"publisher","first-page":"13008","DOI":"10.1074\/jbc.M210366200","volume":"278","author":"A Leask","year":"2003","unstructured":"Leask A, Holmes A, Black CM, Abraham DJ: Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem. 2003, 278: 13008-13015. 10.1074\/jbc.M210366200.","journal-title":"J Biol Chem"},{"key":"1150_CR29","doi-asserted-by":"publisher","first-page":"17058","DOI":"10.1074\/jbc.M100754200","volume":"276","author":"F Verrecchia","year":"2001","unstructured":"Verrecchia F, Chu ML, Mauviel A: Identification of novel TGF-beta\/SMAD gene targets in dermal fibroblasts using a combined cDNA microarray\/promoter transctivation approach. J Biol Chem. 2001, 276: 17058-17062. 10.1074\/jbc.M100754200.","journal-title":"J Biol Chem"},{"key":"1150_CR30","doi-asserted-by":"publisher","first-page":"10594","DOI":"10.1074\/jbc.M010149200","volume":"276","author":"A Holmes","year":"2001","unstructured":"Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 2001, 276: 10594-10601. 10.1074\/jbc.M010149200.","journal-title":"J Biol Chem"},{"key":"1150_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0363-5023(94)90059-0","volume":"19","author":"RJ Alioto","year":"1994","unstructured":"Alioto RJ, Rosier RN, Burton RI, Puzas JE: Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. J Hand Surg Am. 1994, 19: 442-452. 10.1016\/0363-5023(94)90059-0.","journal-title":"J Hand Surg Am"},{"key":"1150_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11552-007-9071-1","volume":"3","author":"S Hindocha","year":"2008","unstructured":"Hindocha S, Stanley JK, Watson JS, Bayat A: Revised tubiana's staging system for assessment of disease severity in dupuytren's disease-Preliminary clinical findings. Hand. 2008, 3: 80-86. 10.1007\/s11552-007-9071-1.","journal-title":"Hand"},{"key":"1150_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0749-0712(21)00443-1","volume":"15","author":"LC Hurst","year":"1999","unstructured":"Hurst LC, Badalamente MA: Nonooperative treatment of Dupuytren's disease. Hand Clinic. 1999, 15: 97-107.","journal-title":"Hand Clinic"},{"key":"1150_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1056\/NEJMoa0810866","volume":"361","author":"LC Hurst","year":"2009","unstructured":"Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J, CORD I Study Group: Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009, 361: 968-979. 10.1056\/NEJMoa0810866.","journal-title":"N Engl J Med"},{"key":"1150_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1302\/0301-620X.81B4.9163","volume":"81","author":"RM Meek","year":"1999","unstructured":"Meek RM, McLellan S, Crossan JF: Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids. J Bone Joint Surg Br. 1999, 81: 732-738. 10.1302\/0301-620X.81B4.9163.","journal-title":"J Bone Joint Surg Br"},{"key":"1150_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1054\/jhsb.2001.0742","volume":"27","author":"RM Meek","year":"2002","unstructured":"Meek RM, McLellan S, Reilly J, Crossan JF: The effect of steroids on Dupuytren's disease: role of programmed cell death. J Hand Surg Br. 2002, 27: 270-273. 10.1054\/jhsb.2001.0742.","journal-title":"J Hand Surg Br"},{"key":"1150_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1053\/jhsu.2000.18493","volume":"25","author":"LD Ketchum","year":"2000","unstructured":"Ketchum LD, Donahue TK: The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000, 25: 1157-1162.","journal-title":"J Hand Surg Am"},{"key":"1150_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1297-3203(00)73455-X","volume":"19","author":"B Jemec","year":"2000","unstructured":"Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA: The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Chir Main. 2000, 19: 15-22. 10.1016\/S1297-3203(00)73455-X.","journal-title":"Chir Main"},{"key":"1150_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jhsb.2003.08.002","volume":"29","author":"NW Bulstrode","year":"2004","unstructured":"Bulstrode NW, Bisson M, Jemec B, Pratt AL, McGrouther DA, Grobbelaar AO: A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of dupuytren's disease. J Hand Surg Br. 2004, 29: 18-21. 10.1016\/j.jhsb.2003.08.002.","journal-title":"J Hand Surg Br"},{"key":"1150_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jcp.46.5.425","volume":"46","author":"KS Baird","year":"1993","unstructured":"Baird KS, Crossan F, Ralston SH: Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol. 1993, 46: 425-428. 10.1136\/jcp.46.5.425.","journal-title":"J Clin Pathol"},{"key":"1150_CR41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","volume":"4","author":"JG Abreu","year":"2002","unstructured":"Abreu JG, Ketpura NI, Reversade B, De Robertis EM: Connective-tissue growth factor (CTGF) modulates cell signaling by BMP and TGF-beta. Nature Cell Biol. 2002, 4: 599-604.","journal-title":"Nature Cell Biol"},{"key":"1150_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jcp.20917","volume":"210","author":"JA Arnott","year":"2007","unstructured":"Arnott JA, Nuglozeh E, Rico MC, Arango-Hisijara I, Odgren PR, Safadi FF, Popoff SN: Connective tissue growth factor (CTGF\/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts. J Cell Physiol. 2007, 210: 843-852. 10.1002\/jcp.20917.","journal-title":"J Cell Physiol"},{"key":"1150_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jcp.20251","volume":"203","author":"S Chujo","year":"2005","unstructured":"Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K: Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. J Cell Physiol. 2005, 203: 447-456. 10.1002\/jcp.20251.","journal-title":"J Cell Physiol"},{"key":"1150_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1359-6101(97)00010-5","volume":"8","author":"GR Grotendorst","year":"1997","unstructured":"Grotendorst GR: Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 1997, 8: 171-179. 10.1016\/S1359-6101(97)00010-5.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1150_CR45","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1524-475X.2008.00416.x","volume":"16","author":"M Sisco","year":"2008","unstructured":"Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, Roy NK, Dean NM, Mustoe TA: Antisense inhibition of connective tissue growth factor (CTGF\/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen. 2008, 16: 661-673. 10.1111\/j.1524-475X.2008.00416.x.","journal-title":"Wound Repair Regen"},{"key":"1150_CR46","doi-asserted-by":"publisher","first-page":"8881","DOI":"10.1038\/sj.onc.1206871","volume":"22","author":"M Schiller","year":"2003","unstructured":"Schiller M, Verrecchia F, Mauviel A: Cyclic adenosine 3',5'-monophosphate-elevating agents inhibit transforming growth factor-beta-induced SMAD3\/4-dependent transcription via a protein kinase A-dependent mechanism. Oncogene. 2003, 22: 8881-8890. 10.1038\/sj.onc.1206871.","journal-title":"Oncogene"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-12-113\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:33:04Z","timestamp":1637713984000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-12-113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-12-113","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,25]]},"article-number":"113"}}